Recombinant bone morphogenetic protein-2 attenuates colorectal cancer progression by orchestrating Hippo pathway activation, Yes-associated protein inhibition, and epithelial--mesenchymal transition suppression.
Saved in:
| Title: | Recombinant bone morphogenetic protein-2 attenuates colorectal cancer progression by orchestrating Hippo pathway activation, Yes-associated protein inhibition, and epithelial--mesenchymal transition suppression. |
|---|---|
| Authors: | Wu, Yanling1, Lee, Na-Ri2,3, Liu, Yu Chuan1, Kim, Min Sun4, Hwang, Seongwon5, Kim, Bumseok5, Lee, Kwang-Bok6 osdr2815@naver.com, Kim, Soo Mi1,3 soomikim@jbnu.ac.kr |
| Source: | Korean Journal of Physiology & Pharmacology. Jul2026, Vol. 30 Issue 4, p361-375. 15p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
